Novozymes A/S (OTCMKTS:NVZMY) Releases Earnings Results, Misses Estimates By $0.31 EPS

Novozymes A/S (OTCMKTS:NVZMY) issued its earnings results on Tuesday. The biotechnology company reported $0.51 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.82 by ($0.31), Zacks reports. The company had revenue of $1.31 billion during the quarter, compared to analyst estimates of $1.32 billion. Novozymes A/S had a return on equity of 6.57% and a net margin of 14.22%.

Novozymes A/S Price Performance

Shares of OTCMKTS:NVZMY traded down $2.10 during midday trading on Thursday, reaching $59.17. 4,420 shares of the company’s stock were exchanged, compared to its average volume of 96,556. The firm has a market capitalization of $24.53 billion, a PE ratio of 39.98, a price-to-earnings-growth ratio of 1.17 and a beta of 0.98. The company’s 50 day simple moving average is $58.31 and its two-hundred day simple moving average is $61.13. Novozymes A/S has a 12 month low of $49.90 and a 12 month high of $75.99. The company has a debt-to-equity ratio of 0.12, a quick ratio of 0.44 and a current ratio of 0.72.

Analyst Ratings Changes

NVZMY has been the topic of a number of recent research reports. Rothschild & Co Redburn upgraded Novozymes A/S to a “strong-buy” rating in a research note on Friday, March 27th. Zacks Research downgraded shares of Novozymes A/S from a “hold” rating to a “strong sell” rating in a report on Monday. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy”.

About Novozymes A/S

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).